News

Precision X-Ray Teams Up with Gilardoni for Blood Irradiation

Precision X-Ray Teams Up with Gilardoni for Blood Irradiation

Precision X-Ray Forms Strategic Partnership with Gilardoni

Precision X-Ray, Inc. has recently forged an exclusive distribution partnership with Gilardoni SpA, aimed at introducing the RADGIL2 blood irradiator to the US market. This innovative device is designed for the safe and effective X-ray irradiation of blood and its components. By utilizing the RADGIL2, healthcare facilities can significantly decrease the risks associated with transfusion-related diseases, particularly Transfusion-associated Graft versus Host Disease (TA-GvHD). This development offers a state-of-the-art alternative to traditional models that use Cesium-137, which poses various safety concerns.

Advantages of the RADGIL2 Blood Irradiator

Innovative Features for Patient Safety

The RADGIL2 stands out in the market due to its advanced features that enhance safety and efficiency. One notable aspect is its high dose rate, which accelerates the irradiation process, leading to faster treatment times. Additionally, the device incorporates rotating canister technology that ensures a consistent and uniform delivery of doses, improving the overall effectiveness of blood irradiation procedures.

CEO Insights on the Collaboration

Viktoriya Baytser, CEO of Precision X-Ray, expressed excitement about this partnership, stating, "Precision is proud and thrilled to partner with Gilardoni to deliver the RADGIL2 blood irradiator in the US. This collaboration will expand our influence in the medical field, reinforcing our commitment to innovative and reliable solutions in X-ray technology, particularly in critical areas like blood irradiation."

Statements from Gilardoni's Leadership

Marco Gilardoni, CEO of Gilardoni SpA, shared his enthusiasm for the alliance, affirming, "We are delighted to partner with a company that is highly regarded in the X-ray irradiation market. Precision's values align with ours in striving to enhance the standard of care for blood irradiation. We are eager to collaborate in establishing the RADGIL2 as the benchmark for blood irradiation in the US."

Explore Precision’s Offering

For further details about the RADGIL2 or other innovative products and services provided by Precision X-Ray, interested parties can visit Precision's official website.

About Precision X-Ray, Inc.

Precision X-Ray is recognized as the largest global manufacturer of cabinet X-ray irradiation systems. With a focus on delivering safe, reliable, and reproducible results, the company has been at the forefront of technological advancement since the early 2000s, catering to partners across various sectors including commercial, agricultural, and academic fields.

About Gilardoni SpA

Established in 1947, Gilardoni SpA has become a leading player in the fields of X-ray and ultrasonic equipment for non-destructive testing and medical applications. With a dedicated workforce of over 200 employees worldwide, the company has been a key innovator in industrial radioscopy since 1968.

Frequently Asked Questions

What is the RADGIL2 blood irradiator?

The RADGIL2 is an advanced X-ray device designed for safe and effective irradiation of blood and blood components, reducing risks related to transfusion-related diseases.

Who are the partners involved in this initiative?

Precision X-Ray, Inc. and Gilardoni SpA have partnered to introduce this cutting-edge technology to the US market.

What are the benefits of using RADGIL2 over traditional methods?

RADGIL2 provides a safer, more efficient method of blood irradiation, with faster processing times and enhanced dose delivery uniformity.

How does this partnership impact the medical field?

This partnership aims to improve patient safety and care standards in blood irradiation, reflecting a commitment to innovative healthcare solutions.

Where can I learn more about Precision X-Ray's products?

For further inquiries about the RADGIL2 or additional products, you can visit Precision X-Ray’s official website for comprehensive information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 58

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 94

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 0

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 113

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Don Silvestri: NFL Vet's Service Legacy Continues

Updated Category News Views 64

More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...

Continue Reading
CORE Embraces Tech to Boost Organ Donation Efforts

Updated Category News Views 73

Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...

Continue Reading
MillerKnoll's 3D Push: Legacy Meets Innovation

Updated Category News Views 42

Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...

Continue Reading
Dotwork's AI Leap: Acquires Arcario to Revolutionize Strategy

Updated Category News Views 84

Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...

Continue Reading
Boeing's Third Quarter 2026: Progress Amid Losses

Updated Category News Views 97

Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...

Continue Reading

Top 5 Most Recently Viewed Articles

SMCP Reports Strong Sales Growth Backed by Strategic Plans

Updated Category News Views 229

Strong Sales Growth in Q3 for SMCP The latest sales report for SMCP has highlighted a solid growth trajectory in the third quarter. The performance is attributed to robust activities in the America and EMEA regions, showcasing the effectiveness of the company's strategic initiatives. Sales Overview and Highlights In the first nine months of 2025, SMCP achieved impressive...

Continue Reading
InflaRx Set to Showcase Innovations at Upcoming Investor Events

Updated Category News Views 187

InflaRx to Participate in Major Investor Conferences In a noteworthy announcement, InflaRx N.V. (Nasdaq: IFRX), a leading biopharmaceutical company specializing in anti-inflammatory therapeutics, is gearing up for participation in two significant investor conferences in September. This engagement comes as the company continues to push boundaries in treating inflammatory...

Continue Reading
Rapid7's Participation at Major Industry Conference

Updated Category News Views 141

Rapid7 to Attend Prominent Conference Rapid7, Inc. (NASDAQ:RPD), a frontrunner in threat detection and exposure management, has recently announced its participation in a significant event: the Raymond James TMT and Consumer Conference. This notable conference will take place in New York, providing a platform where industry leaders gather to discuss innovations and...

Continue Reading
Theriva Biologics Expands Opportunities with New Offering

Updated Category News Views 136

Theriva Biologics Expands Opportunities with New Offering Theriva Biologics (NYSE American: TOVX), a clinical-stage company focused on developing innovative cancer therapeutics, has recently completed a significant public offering aimed at raising $7.5 million. This initiative is not only a financial step for Theriva but also a strategic move to enhance its research...

Continue Reading
Costco Welcomes Gina Raimondo to its Board of Directors

Updated Category News Views 211

Costco's New Board Nominee Costco Wholesale Corporation (NASDAQ: COST) has announced the nomination of Gina Raimondo to its Board of Directors. Raimondo, who has an impressive track record, served as the 40th Secretary of Commerce and held the position of Governor of Rhode Island. Her political career began in 2010 when she was elected as the Treasurer of Rhode Island....

Continue Reading